Brooke M. Pancoe - Jan 2, 2024 Form 3/A Insider Report for ARROW FINANCIAL CORP (AROW)

Role
EVP, Chief HR Officer
Signature
Penko Ivanov, Attorney in Fact
Stock symbol
AROW
Transactions as of
Jan 2, 2024
Transactions value $
$0
Form type
3/A
Date filed
5/28/2024, 11:38 AM
Date Of Original Report
Apr 29, 2024
Next filing
May 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AROW Common Stock 513 Jan 2, 2024 Direct
holding AROW Common Stock 25 Jan 2, 2024 Held by spounse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AROW Employee Stock Option (Right to Buy) Jan 2, 2024 Common Stock 1.09K $27.04 Direct F2
holding AROW Employee Stock Option (Right to Buy) Jan 2, 2024 Common Stock 1.59K $33.78 Direct F3
holding AROW Employee Stock Option (Right to Buy) Jan 2, 2024 Common Stock 1.55K $31.47 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for any purpose.
F2 The options vest 25% per year in equal installments, starting one year from the grant date. One quarter of the options vested and became exercisable on each of January 27, 2022; January 27, 2023, and January 27 2024; one quarter will vest and become exercisable on January 27, 2025.
F3 The options vest 25% per year in equal installments, starting one year from the grant date. One quarter of the options vested and became exercisable on each of January 26, 2023 and January 26, 2024; one quarter will vest and become exercisable on each of January 26, 2025 and January 26, 2026.
F4 The options vest 25% per year in equal installments, starting one year from the grant date. One quarter of the options vested and became exercisable on February 1, 2024; one quarter will vest and become exercisable on each of February 1, 2025; February 1, 2026, and February 1, 2027.

Remarks:

This Form 3/A is filed to amend the Form 3 filed by the Reporting Person on April 29, 2024 (the "Original Form 3"). The Original Form 3 is hereby amended to update the vesting schedule of certain options issued to the Reporting Person.